Carina
10-16-2006, 04:58 PM
Hello Everyone,
Since I have always gotten a straight and informed answer from this site I thought I would ask the following:
I was reading an abstract of an article (Diindolylmethane (DIM) and Paclitaxel Act Synergistically to Promot apoptosis in HER2/Neu Human Breast Cancer Cells, Jan 2006, Journal of Surgery) and came across a reference to the resistance of HER2-neu tumours to chemotherapy. As an aside, the article noted that HER2-neu overexpression confers resistance to paclitaxel. Unfortunately I could not access the full text of the article. Has anyone heard of any studies looking at the resistance of HER2-neu tumours to paclitaxel or the other taxanes?
Keep well,
Carina
Since I have always gotten a straight and informed answer from this site I thought I would ask the following:
I was reading an abstract of an article (Diindolylmethane (DIM) and Paclitaxel Act Synergistically to Promot apoptosis in HER2/Neu Human Breast Cancer Cells, Jan 2006, Journal of Surgery) and came across a reference to the resistance of HER2-neu tumours to chemotherapy. As an aside, the article noted that HER2-neu overexpression confers resistance to paclitaxel. Unfortunately I could not access the full text of the article. Has anyone heard of any studies looking at the resistance of HER2-neu tumours to paclitaxel or the other taxanes?
Keep well,
Carina